American Bitcoin Corp., co-founded by Eric Trump, has seen its shares collapse 95% from a peak of $139.65, erasing over $600 million from Trump's roughly 6% stake. The stock debuted in September 2025 and has declined steadily, forcing a 1-for-15 reverse split to maintain its Nasdaq listing. While competitors pivoted to AI-related deals and gained over 60% in 2026, American Bitcoin stuck to bitcoin mining and accumulation. Meanwhile, a separate $107 million leveraged ether trade highlights ongoing high-stakes bets in crypto markets. Eric Trump remains bullish on bitcoin despite the losses, predicting it could reach $1 million per coin eventually.
The 2026 SANS AI Survey reveals rapid AI adoption in cybersecurity, with 78% of organizations using AI, up from 50% last year. However, governance structures and formal audit frameworks have not kept pace, leading to increased AI-related failures in ...
The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...
Noble Capital Markets has initiated equity research coverage on VivoPower PLC, assigning an Outperform rating and setting a price target of $10. VivoPower is a B Corp-certified global developer of powered land and data center infrastructure for AI ap...
Alamar Biosciences has partnered with leading U.S. universities to launch a nationwide proteomics study analyzing around 21,000 plasma samples from 10,000 Alzheimer's and related dementia patients. Using its NULISAseq™ Neuro 220 test kit, the project...
Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...
